For the first time in Turkey, biosimilar parathormone was produced domestically and nationally. This hormone, on which our country spends about 16 million Turkish Lira each year, is necessary for parathyroid hormone deficiencies, especially for osteoporosis, bone and cartilage abrasions, and fractures that do not heal, which develops postmenopausal period in women. This hormone, which is sold for about $ 3.200 per box in the world, is a replica of the natural parathormone in the body because it is biosimilar.
In consequence of a 5 million TL investment and two years of hard work by a crowded team led by Yeditepe University Faculty Members of Prof. Dr Fikrettin Şahin, Prof. Dr Erhan Ayşan, Asst. Prof. Emrah Nikerel, biosimilar parathormone production was realized for the first time in Turkey. The hormone has reached its final stage in the production phase and is expected to be on the shelves after the licensing process.
You can visit yeditepehealthcare.org for the rest of the news.